Financials data is unavailable for this security.
View more
Year on year Nath Bio-Genes (I) Ltd grew revenues 10.37% from 3.01bn to 3.33bn while net income improved 13.16% from 350.11m to 396.19m.
Gross margin | 90.78% |
---|---|
Net profit margin | 11.69% |
Operating margin | 14.60% |
Return on assets | -- |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, Nath Bio-Genes (I) Ltd increased its cash reserves by 103.74%, or 394.15m. The company earned 745.94m from its operations for a Cash Flow Margin of 22.43%. In addition the company used 274.01m on investing activities and also paid 77.78m in financing cash flows.
Cash flow per share | 22.72 |
---|---|
Price/Cash flow per share | 9.42 |
Book value per share | -- |
---|---|
Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
Current ratio | -- |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 13.16%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg) | 0.84% |
---|---|
Div growth rate (5 year) | -- |
Payout ratio (TTM) | 9.53% |
EPS growth(5 years) | 0.6092 |
---|---|
EPS (TTM) vs TTM 1 year ago | 5.89 |
More ▼